论文部分内容阅读
用米托蒽醌联合阿糖胞苷治疗 32例急性髓细胞白血病 ,有效率 81 3% ,较经典的柔红霉素治疗的心脏毒性小 ,但胃肠道及骨髓抑制等毒副作用明显加重
Treatment of 32 cases of acute myeloid leukemia with mitoxantrone combined with cytarabine has an efficacy rate of 81 3%, which is lower than the classic cardiotoxicity of daunorubicin, but the side effects such as gastrointestinal tract and bone marrow suppression are obviously aggravated.